Canada Pension Plan Investment Board
CLDX icon

Canada Pension Plan Investment Board’s Celldex Therapeutics CLDX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-37,000
Closed -$935K – 1337
2024
Q4 		$935K Sell
37,000
-27,000
-42% -$734K ﹤0.01% 1030
2024
Q3 		$2.18M Buy
+64,000
New +$2.44M ﹤0.01% 854
2022
Q1 		– Sell
-23,600
Closed -$912K – 1352
2021
Q4 		$912K Buy
23,600
+12,600
+115% +$549K ﹤0.01% 1052
2021
Q3 		$594K Buy
+11,000
New +$516K ﹤0.01% 1117
2017
Q4 		– Sell
-5,080
Closed -$218K – 1178
2017
Q3 		$218K Sell
5,080
-9,827
-66% -$368K ﹤0.01% 1033
2017
Q2 		$552K Buy
14,907
+1,320
+10% +$58.4K ﹤0.01% 977
2017
Q1 		$736K Buy
13,587
+7,014
+107% +$365K ﹤0.01% 942
2016
Q4 		$349K Buy
6,573
+413
+7% +$23.5K ﹤0.01% 895
2016
Q3 		$373K Buy
6,160
+1,973
+47% +$123K ﹤0.01% 907
2016
Q2 		$276K Buy
4,187
+1,194
+40% +$75.8K ﹤0.01% 935
2016
Q1 		$170K Buy
2,993
+2,253
+304% +$253K ﹤0.01% 1015
2015
Q4 		$174K Sell
740
-6,712
-90% -$1.46M ﹤0.01% 1021
2015
Q3 		$1.18M Buy
7,452
+7,245
+3,500% +$2.05M ﹤0.01% 820
2015
Q2 		$78K Sell
207
-226
-52% -$89.8K ﹤0.01% 1147
2015
Q1 		$181K Buy
+433
New +$155K ﹤0.01% 1031

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Canada Pension Plan Investment Board's CLDX Position: Q1 2025 in Review

Canada Pension Plan Investment Board sold out of Celldex Therapeutics (CLDX) in Q1 2025, closing a stake of 37,000 shares — an estimated $935K sold.

Canada Pension Plan Investment Board first reported a position in CLDX in Q1 2015 and held it in 15 quarters. The position peaked at $2.18M in Q3 2024. 171 funds tracked by Wall St. Rank hold CLDX as of Q1 2025.

  • Canada Pension Plan Investment Board reported no remaining Celldex Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 37,000 Celldex Therapeutics shares in Q1 2025, an estimated $935K.
  • Canada Pension Plan Investment Board first reported a position in Celldex Therapeutics in Q1 2015 and held it in 15 quarters.
  • Canada Pension Plan Investment Board's Celldex Therapeutics position peaked at $2.18M in Q3 2024.
  • 171 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q1 2025.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2025, filed 15 May 2025.